Literature DB >> 23615804

Patient tailored resection planning in patients undergoing liver surgery for colorectal liver metastases; how and why should you do it?

C S van Kessel1, M S van Leeuwen, R van Hillegersberg, I H M Borel Rinkes, M A A J van den Bosch, I Q Molenaar.   

Abstract

BACKGROUND: A systematic preoperative evaluation to determine the individual resection strategy in patients with colorectal liver metastases (CRLM) was assessed as to its clinical value. PATIENTS AND METHODS: From 2009 to 2011, 75 patients with CRLM who were scheduled for surgery were prospectively included and received an additional preoperative systematic evaluation in the presence of a hepatobiliary radiologist and the hepatobiliary surgeon scheduled to perform the surgery. The following items were assessed in a standardized manner: lesion detection and characterization, presence of extrahepatic disease, vascular anatomy, and resection strategy. Intraoperative findings and histopathological results were prospectively recorded.
RESULTS: Five out of 75 patients were not considered to be eligible for surgery due to additional findings, such as additional metastases or extrahepatic disease. Sensitivity and specificity for detection of individual CRLM were 80.9% (95% CI 75.7-86.1%) and 69.1% (95% CI 59.1-79.1%), respectively. Radical resections were performed in 87.1%. There was one futile laparotomy (1.4%).
CONCLUSION: In patients with colorectal liver metastases, standardized preoperative work-up, with subsequent planning of an individualized resection in a jointed meeting of a hepatobiliary radiologist and the surgeon who will perform the operation, leads to a high level of radical resections and a low number of futile laparotomies.

Entities:  

Mesh:

Year:  2013        PMID: 23615804     DOI: 10.1007/s11605-013-2185-6

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  33 in total

1.  New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

Authors:  P Therasse; S G Arbuck; E A Eisenhauer; J Wanders; R S Kaplan; L Rubinstein; J Verweij; M Van Glabbeke; A T van Oosterom; M C Christian; S G Gwyther
Journal:  J Natl Cancer Inst       Date:  2000-02-02       Impact factor: 13.506

Review 2.  Neoadjuvant therapy of colorectal liver metastases: lessons learned from clinical trials.

Authors:  Antoine Brouquet; Bernard Nordlinger
Journal:  J Surg Oncol       Date:  2010-12-15       Impact factor: 3.454

3.  Reappraisal of right portal segmental ramification based on 3-dimensional volume rendering of computed tomography during arterial portography.

Authors:  Te-Chang Wu; Rheun-Chuan Lee; Gar-Yang Chau; Jen-Huey Chiang; Cheng-Yen Chang
Journal:  J Comput Assist Tomogr       Date:  2007 May-Jun       Impact factor: 1.826

4.  Identification of the anterior sectoral trunk with particular reference to the hepatic hilar plate and its clinical importance.

Authors:  Hee Chul Yu; Zhe Wu Jin; Guang Yu Jin; Heecheon You; Jang Il Moon; Jin Wook Chung; Shin Hwang; Baik Hwan Cho
Journal:  Surgery       Date:  2010-01-15       Impact factor: 3.982

5.  Hepatic and extrahepatic colorectal metastases: when resectable, their localization does not matter, but their total number has a prognostic effect.

Authors:  Dominique Elias; Gabriel Liberale; Déwi Vernerey; Marc Pocard; Michel Ducreux; Valérie Boige; David Malka; Jean-Pierre Pignon; Philippe Lasser
Journal:  Ann Surg Oncol       Date:  2005-09-26       Impact factor: 5.344

6.  Complete response of colorectal liver metastases after chemotherapy: does it mean cure?

Authors:  Stéphane Benoist; Antoine Brouquet; Christophe Penna; Catherine Julié; Mostafa El Hajjam; Sophie Chagnon; Emmanuel Mitry; Philippe Rougier; Bernard Nordlinger
Journal:  J Clin Oncol       Date:  2006-08-20       Impact factor: 44.544

7.  Resection of colorectal liver metastases.

Authors:  Eddie K Abdalla
Journal:  J Gastrointest Surg       Date:  2011-02-08       Impact factor: 3.452

8.  Is hepatic resection justified after chemotherapy in patients with colorectal liver metastases and lymph node involvement?

Authors:  René Adam; Robbert J de Haas; Dennis A Wicherts; Thomas A Aloia; Valérie Delvart; Daniel Azoulay; Henri Bismuth; Denis Castaing
Journal:  J Clin Oncol       Date:  2008-08-01       Impact factor: 44.544

9.  Genetic and histological assessment of surgical margins in resected liver metastases from colorectal carcinoma: minimum surgical margins for successful resection.

Authors:  Norihiro Kokudo; Yoshio Miki; Sachiko Sugai; Akio Yanagisawa; Yo Kato; Yoshihiro Sakamoto; Junji Yamamoto; Toshiharu Yamaguchi; Tetsuichiro Muto; Masatoshi Makuuchi
Journal:  Arch Surg       Date:  2002-07

Review 10.  Expanding criteria for resectability of colorectal liver metastases.

Authors:  Timothy M Pawlik; Richard D Schulick; Michael A Choti
Journal:  Oncologist       Date:  2008-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.